190 related articles for article (PubMed ID: 21641053)
1. Evaluation of neointimal coverage and apposition with various drug-eluting stents over 12 months after implantation by optical coherence tomography.
Li S; Wang Y; Gai L; Yang T; Liu H; Wang Z; Bai Q; Xu X; Chen Y
Int J Cardiol; 2013 Jan; 162(3):166-71. PubMed ID: 21641053
[TBL] [Abstract][Full Text] [Related]
2. Different vascular healing patterns with various drug-eluting stents in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: optical coherence tomographic findings.
Fan C; Kim JS; Lee JM; Kim TH; Park SM; Wi J; Paik SI; Ko YG; Choi D; Hong MK; Jang Y
Am J Cardiol; 2010 Apr; 105(7):972-6. PubMed ID: 20346315
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the peri-strut low intensity area following sirolimus- and paclitaxel-eluting stents implantation: insights from an optical coherence tomography study in humans.
Otake H; Shite J; Ikeno F; Shinke T; Teramoto T; Miyoshi N; Ako J; Honda Y; Fitzgerald PJ; Hirata K
Int J Cardiol; 2012 May; 157(1):38-42. PubMed ID: 21168926
[TBL] [Abstract][Full Text] [Related]
4. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
[TBL] [Abstract][Full Text] [Related]
5. Different serial changes in the neointimal condition of sirolimus-eluting stents and paclitaxel-eluting stents: an optical coherence tomographic study.
Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y; Hara M; Sakata Y; Hamasaki T; Nishino M
EuroIntervention; 2014 Dec; 10(8):924-33. PubMed ID: 24602858
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
[TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomographic comparison of neointimal coverage between sirolimus- and resolute zotarolimus-eluting stents at 9 months after stent implantation.
Kim JS; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Int J Cardiovasc Imaging; 2012 Aug; 28(6):1281-7. PubMed ID: 21858655
[TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent.
Toledano Delgado FJ; Alvarez-Ossorio MP; de Lezo Cruz-Conde JS; Bellido FM; Romero Moreno MÁ; Fernández-Aceytuno AM; de Lezo Herrerosde Tejada JS; Pineda SO; Saint-Gerons JM; Pavlovic D
Catheter Cardiovasc Interv; 2014 Nov; 84(5):720-6. PubMed ID: 24174291
[TBL] [Abstract][Full Text] [Related]
9. Six-month follow-up evaluation for everolimus-eluting stents by intracoronary optical coherence tomography: comparison with paclitaxel-eluting stents.
Takano M; Murakami D; Yamamoto M; Kurihara O; Murai K; Inami T; Kimata N; Ohba T; Seino Y; Mizuno K
Int J Cardiol; 2013 Jun; 166(1):181-6. PubMed ID: 22075410
[TBL] [Abstract][Full Text] [Related]
10. Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography.
Kim S; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Cho YK; Nam CW; Hur SH; Jang Y; Hong MK
Am J Cardiol; 2013 Jan; 111(1):1-5. PubMed ID: 23040589
[TBL] [Abstract][Full Text] [Related]
11. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
[TBL] [Abstract][Full Text] [Related]
12. Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents.
Kim JS; Jang IK; Kim JS; Kim TH; Takano M; Kume T; Hur NW; Ko YG; Choi D; Hong MK; Jang Y
Heart; 2009 Dec; 95(23):1907-12. PubMed ID: 19535352
[TBL] [Abstract][Full Text] [Related]
13. Comparison of vascular responses after different types of second-generation drug-eluting stents implantation detected by optical coherence tomography.
Ohtani H; Kimura S; Sugiyama T; Hishikari K; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Kojima K; Sagawa Y; Hikita H; Ashikaga T; Takahashi A; Isobe M
Int J Cardiovasc Imaging; 2017 Feb; 33(2):177-186. PubMed ID: 27761750
[TBL] [Abstract][Full Text] [Related]
14. ComparisOn of neointimal coVerage betwEen zotaRolimus-eluting stent and everolimus-eluting stent using Optical Coherence Tomography (COVER OCT).
Kim JS; Kim BK; Jang IK; Shin DH; Ko YG; Choi D; Hong MK; Cho YK; Nam CW; Hur SH; Choi JH; Song YB; Hahn JY; Choi SH; Gwon HC; Jang Y
Am Heart J; 2012 Apr; 163(4):601-7. PubMed ID: 22520526
[TBL] [Abstract][Full Text] [Related]
15. Drug-eluting stent implantation in patients with acute coronary syndrome - the Activity of Platelets after Inhibition and Cardiovascular Events: Optical Coherence Tomography (APICE OCT) study.
Chieffo A; Buchanan GL; Parodi G; Versaci F; Bianchi RM; Valenti R; Saccà S; Mongiardo A; Span S; Migliorini A; Spaccarotella C; Reimers B; Antoniucci D; Indolfi C; Ferrari A; Maehara A; Mintz GS; Colombo A
EuroIntervention; 2014 Dec; 10(8):916-23. PubMed ID: 24974806
[TBL] [Abstract][Full Text] [Related]
16. Tissue coverage of paclitaxel and sirolimus eluting stents in long term follow-up: optical coherence tomography study.
Kochman J; Pietrasik A; Rdzanek A; Ścibisz A; Pawlak M; Filipiak KJ; Opolski G
Cardiol J; 2013; 20(3):247-53. PubMed ID: 23788298
[TBL] [Abstract][Full Text] [Related]
17. Comparison of zotarolimus-eluting stent and everolimus-eluting stent for vascular healing response: serial 3-month and 12-month optical coherence tomography study.
Kim SJ; Lee H; Cho JM; Park CB; Kim W; Kato K; Yonetsu T; Kim CJ; Jang IK
Coron Artery Dis; 2013 Aug; 24(5):431-9. PubMed ID: 23722649
[TBL] [Abstract][Full Text] [Related]
18. Serial optical coherence tomography-based observation of strut coverage on drug-eluting stent crossing side-branch vessels.
Lee SY; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
J Invasive Cardiol; 2012 Nov; 24(11):569-73. PubMed ID: 23117310
[TBL] [Abstract][Full Text] [Related]
19. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study.
Davlouros PA; Nikokiris G; Karantalis V; Mavronasiou E; Xanthopoulou I; Damelou A; Tsigkas G; Alexopoulos D
Int J Cardiol; 2011 Sep; 151(2):155-9. PubMed ID: 20605242
[TBL] [Abstract][Full Text] [Related]
20. Neointimal coverage on drug-eluting stent struts crossing side-branch vessels using optical coherence tomography.
Her AY; Lee BK; Shim JM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Am J Cardiol; 2010 Jun; 105(11):1565-9. PubMed ID: 20494663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
